Entacapone and Bronchitis - a phase IV clinical study of FDA data

Summary:

Bronchitis is reported as a side effect among people who take Entacapone (entacapone), especially for people who are female, 60+ old, also take Sinemet, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Bronchitis when taking Entacapone. It is created by eHealthMe based on reports of 4,239 people who have side effects when taking Entacapone from the FDA, and is updated regularly.

What is Entacapone?

Entacapone has active ingredients of entacapone. It is often used in parkinson's disease. eHealthMe is studying from 4,261 Entacapone users. Check the latest studies of Entacapone.

What is Bronchitis?

Bronchitis (inflammation of the mucous membrane in the bronchial tubes) is found to be associated with 2,327 drugs and 2,440 conditions by eHealthMe. Check the latest studies of Bronchitis.

On Jul, 24, 2026

4,239 people reported to have side effects when taking Entacapone.
Among them, 13 people (0.31%) have Bronchitis.

Among these 13 people:

What is the gender of people who have Bronchitis when taking Entacapone? *

female: 84.62 %
male: 15.38 %

What is the age of people who have Bronchitis when taking Entacapone? *

What are other drugs people take besides Entacapone? *

Allegra: 10 people, 76.92%
Sinemet: 10 people, 76.92%
Rytary: 9 people, 69.23%
Magnesium: 9 people, 69.23%
Prevacid: 8 people, 61.54%
Ambien: 8 people, 61.54%
Fluticasone Propionate: 7 people, 53.85%
Singulair: 7 people, 53.85%
Combivent: 7 people, 53.85%
Flonase: 7 people, 53.85%

What are other side effects people have besides Bronchitis? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 8 people, 61.54%
Urinary Tract Infection: 8 people, 61.54%
Fainting (loss of consciousness and postural tone): 7 people, 53.85%
Lower Limb Fracture: 7 people, 53.85%
Rashes (redness): 7 people, 53.85%
Infusion Site Extravasation (flow of (blood or lymph) from infusion site): 7 people, 53.85%
Oedema (fluid collection in tissue): 7 people, 53.85%
Infusion Site Pruritus (severe itching at infusion site): 7 people, 53.85%
Headache (pain in head): 6 people, 46.15%
Localised Infection (infection at the single location): 6 people, 46.15%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 7 people, 53.85%
Pain: 2 people, 15.38%
On And Off Phenomenon: 2 people, 15.38%
Lung Disorder (lung disease): 2 people, 15.38%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 7.69%
Impaired Gastric Emptying: 1 person, 7.69%
Cardiac Disorder: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Entacapone and have Bronchitis?

- Check whether Bronchitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Entacapone:

Entacapone (4,261 reports)

Bronchitis treatments and more:

Bronchitis (118,921 reports)

Browse all side effects of Entacapone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bronchitis:

Bronchitis (2,327 drugs)

Browse all the conditions that are associated with Bronchitis:

Bronchitis (2,440 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on entacapone (the active ingredients of Entacapone) and Entacapone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.